Most patients with dystroglycanopathy present with mutations in one of the 19 genes required for the glycosylation of Dystroglycan, resulting in hypoglycosylated Dystroglycan. The gene discussed is DAG1; the disease is neuromuscular disease caused by qualitative or quantitative defects of alpha-dystroglycan.